Mironid Ltd: Innovative Drug Discovery

University of Strathclyde Background
Mironid Limited is an innovative drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows access to multiple therapeutic areas for exploitation. Current drug discovery pipeline is aimed at developing novel treatments for degenerative kidney diseases, chronic inflammatory diseases and cancer.
Technology Overview
Mironid’s unique Physiology Mirroring approach uses deep biological knowledge of cell signalling to design assays that mirror the drug target’s conformation and environment found in living cells. This allows the team to dial-up and down the activity of key cell signalling enzymes to rebalance aberrant signals that drive different disease states.
Further Details


Potential uses for Mironid’s technology are in the pharmaceutical industry.

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More